课题基金 / 基金详情

ROLE OF INTESTINAL UGT'S ON IRINOTECAN DISPOSITION

ROLE OF INTESTINAL UGT'S ON IRINOTECAN DISPOSITION
肠道 UGT 对伊立替康处置的作用
批准号:
7377428
负责人:
BERT Howard O'NEIL
金额:
$0.82万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-12-01 至 2006-11-30

项目摘要

项目成果

BERT Howard O'NEIL的其他基金

相似基金

相关文献

中文摘要
翻译
该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者(PI)可能从另一个NIH来源获得了主要资金,因此可以在其他CRISP条目中表示。所列机构为中心机构,不一定为研究者机构。本研究的目的是找出伊立替康引起腹泻的途径。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to find out the way that irinotecan causes diarrhea.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: A PHASE II STUDY OF AZD6244 IN ADVANCED OR METASTATIC HEPATOCELL
Radiation-induced signaling and treatment resistance
Radiation-induced signaling and treatment resistance
Radiation-induced signaling and treatment resistance
海外基金